Correlation Between Quantum Genomics and Neovacs SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quantum Genomics and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum Genomics and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quantum Genomics SA and Neovacs SA, you can compare the effects of market volatilities on Quantum Genomics and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum Genomics with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum Genomics and Neovacs SA.

Diversification Opportunities for Quantum Genomics and Neovacs SA

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Quantum and Neovacs is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Quantum Genomics SA and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Quantum Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum Genomics SA are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Quantum Genomics i.e., Quantum Genomics and Neovacs SA go up and down completely randomly.

Pair Corralation between Quantum Genomics and Neovacs SA

Assuming the 90 days trading horizon Quantum Genomics SA is expected to under-perform the Neovacs SA. But the stock apears to be less risky and, when comparing its historical volatility, Quantum Genomics SA is 60.12 times less risky than Neovacs SA. The stock trades about -0.21 of its potential returns per unit of risk. The Neovacs SA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.03  in Neovacs SA on August 24, 2024 and sell it today you would lose (0.01) from holding Neovacs SA or give up 33.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Quantum Genomics SA  vs.  Neovacs SA

 Performance 
       Timeline  
Quantum Genomics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Genomics SA are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Quantum Genomics reported solid returns over the last few months and may actually be approaching a breakup point.
Neovacs SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neovacs SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Quantum Genomics and Neovacs SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quantum Genomics and Neovacs SA

The main advantage of trading using opposite Quantum Genomics and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum Genomics position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.
The idea behind Quantum Genomics SA and Neovacs SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA